drugset / Trial / NCT00380406
PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
Phase 3
Completed
30 enrolled
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR) · collabQueen's University · collabUniversity of Ottawa · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether gonadotropin releasing hormone agonists (medical therapy) will protect against ovarian failure in reproductive aged women undergoing sterilizing chemotherapy.
Timeline
- Start
- 2007-01
- Primary completion
- 2010-01
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Leuprolide | Other / unclassified | 11.25 mg | Intramuscular |